Search Results - "Vigklis, V"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Impaired phagocytosis among patients infected by the human immunodeficiency virus: implication for a role of highly active anti‐retroviral therapy by Michailidis, C., Giannopoulos, G., Vigklis, V., Armenis, K., Tsakris, A., Gargalianos, P.

    Published in Clinical and experimental immunology (01-03-2012)
    “…Summary In patients with human immunodeficiency virus (HIV) infection, neutrophil and monocyte functions, including phagocytosis, are impaired. The purpose of…”
    Get full text
    Journal Article
  2. 2

    Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down‐regulation of the T cell costimulatory molecule CD40 ligand: An open‐label trial by Sfikakis, P. P., Boletis, J. N., Lionaki, S., Vigklis, V., Fragiadaki, K. G., Iniotaki, A., Moutsopoulos, H. M.

    Published in Arthritis and rheumatism (01-02-2005)
    “…Objective Autoreactive B cells play a key role in tissue injury in systemic autoimmune disease, and therefore a treatment resulting in B cell depletion could…”
    Get full text
    Journal Article
  3. 3

    Low-dose IFN-alpha monotherapy in treatment-naive individuals with HIV-1 infection: evidence of potent suppression of viral replication by Hatzakis, A, Gargalianos, P, Kiosses, V, Lazanas, M, Sypsa, V, Anastassopoulou, C, Vigklis, V, Sambatakou, H, Botsi, C, Paraskevis, D, Stalgis, C

    Published in Journal of interferon & cytokine research (01-10-2001)
    “…To evaluate the safety and antiviral action of interferon-alpha (IFN-alpha) in HIV-1 infection, we undertook a proof of concept study in 27 treatment-naive…”
    Get more information
    Journal Article
  4. 4

    Immunologic profile of HIV-1 infected patients after administration of pegylated interferon- alpha -2b (PEG-intron) by Vigklis, V, Laughlin, M, Gargalianos, P, Lazanas, M, Botsi, C, Saroglou, G, Sabatakou, H, Paraskeva, D, Stavrianeas, N, Mavroidi, N, Glue, P, Hatzakis, A

    Published in AIDS (London) (01-10-2000)
    “…PEG-intron is a formulation of interferon-a2b (IFN-a) that provides prolonged activity by significantly increasing its serum half-life. Earlier work in vitro…”
    Get full text
    Journal Article